New diagnostic imaging tool monitors fate of cell therapies in cancer patients

A pilot study at University of California San Diego School of Medicine debuts a novel method to monitor the survival of a cancer cell therapy using a fluorine-based nanoemulsion agent to "tag" cells prior to patient infusion. The tag enables magnetic resonance imaging (MRI) detection of a cell therapy product (i.e. engineered T cells) post-delivery.